Cargando…
Cellular phenotypic transitions in diabetic nephropathy: An update
Diabetic nephropathy (DN) is a major cause of morbidity and mortality in diabetes and is the most common cause of end stage renal disease (ESRD). Renal fibrosis is the final pathological change in DN. It is widely believed that cellular phenotypic switching is the cause of renal fibrosis in diabetic...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666367/ https://www.ncbi.nlm.nih.gov/pubmed/36408221 http://dx.doi.org/10.3389/fphar.2022.1038073 |
_version_ | 1784831489442054144 |
---|---|
author | Cao, Yiling Lin, Ji-Hong Hammes, Hans-Peter Zhang, Chun |
author_facet | Cao, Yiling Lin, Ji-Hong Hammes, Hans-Peter Zhang, Chun |
author_sort | Cao, Yiling |
collection | PubMed |
description | Diabetic nephropathy (DN) is a major cause of morbidity and mortality in diabetes and is the most common cause of end stage renal disease (ESRD). Renal fibrosis is the final pathological change in DN. It is widely believed that cellular phenotypic switching is the cause of renal fibrosis in diabetic nephropathy. Several types of kidney cells undergo activation and differentiation and become reprogrammed to express markers of mesenchymal cells or podocyte-like cells. However, the development of targeted therapy for DN has not yet been identified. Here, we discussed the pathophysiologic changes of DN and delineated the possible origins that contribute to myofibroblasts and podocytes through phenotypic transitions. We also highlight the molecular signaling pathways involved in the phenotypic transition, which would provide valuable information for the activation of phenotypic switching and designing effective therapies for DN. |
format | Online Article Text |
id | pubmed-9666367 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96663672022-11-17 Cellular phenotypic transitions in diabetic nephropathy: An update Cao, Yiling Lin, Ji-Hong Hammes, Hans-Peter Zhang, Chun Front Pharmacol Pharmacology Diabetic nephropathy (DN) is a major cause of morbidity and mortality in diabetes and is the most common cause of end stage renal disease (ESRD). Renal fibrosis is the final pathological change in DN. It is widely believed that cellular phenotypic switching is the cause of renal fibrosis in diabetic nephropathy. Several types of kidney cells undergo activation and differentiation and become reprogrammed to express markers of mesenchymal cells or podocyte-like cells. However, the development of targeted therapy for DN has not yet been identified. Here, we discussed the pathophysiologic changes of DN and delineated the possible origins that contribute to myofibroblasts and podocytes through phenotypic transitions. We also highlight the molecular signaling pathways involved in the phenotypic transition, which would provide valuable information for the activation of phenotypic switching and designing effective therapies for DN. Frontiers Media S.A. 2022-11-02 /pmc/articles/PMC9666367/ /pubmed/36408221 http://dx.doi.org/10.3389/fphar.2022.1038073 Text en Copyright © 2022 Cao, Lin, Hammes and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Cao, Yiling Lin, Ji-Hong Hammes, Hans-Peter Zhang, Chun Cellular phenotypic transitions in diabetic nephropathy: An update |
title | Cellular phenotypic transitions in diabetic nephropathy: An update |
title_full | Cellular phenotypic transitions in diabetic nephropathy: An update |
title_fullStr | Cellular phenotypic transitions in diabetic nephropathy: An update |
title_full_unstemmed | Cellular phenotypic transitions in diabetic nephropathy: An update |
title_short | Cellular phenotypic transitions in diabetic nephropathy: An update |
title_sort | cellular phenotypic transitions in diabetic nephropathy: an update |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666367/ https://www.ncbi.nlm.nih.gov/pubmed/36408221 http://dx.doi.org/10.3389/fphar.2022.1038073 |
work_keys_str_mv | AT caoyiling cellularphenotypictransitionsindiabeticnephropathyanupdate AT linjihong cellularphenotypictransitionsindiabeticnephropathyanupdate AT hammeshanspeter cellularphenotypictransitionsindiabeticnephropathyanupdate AT zhangchun cellularphenotypictransitionsindiabeticnephropathyanupdate |